Prelude Therapeutics Announces Fourth Quarter and Full Year 2020 Financial Results and Provides Operational Update

NEXT STORY
Vaccinex Reports Fourth Quarter 2020 Financial Results and Provides Corporate Update
PREV STORY
Blood Cell Separation Market 2021 | Market Size, Share, Growth, Trends, Competitive Landscape, Revenue, Forecast Report 2021-2028
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

BeiGene Announces Clinical Data on Tislelizumab and Pamiparib Presented at the European Society for Medical Oncology (ESMO) Congress 2019

author_avatar
NASDAQ Market News

Kura Oncology Reports First Quarter 2017 Operational and Financial Results

LA JOLLA, Calif., May 15, 2017 (GLOBE NEWSWIRE) -- Kura Oncology, Inc., (NASDAQ:KURA) a ...

author_avatar
NASDAQ Market News

Lenabasum Open-Label Extension Data to be Presented at EULAR 2019 Continue to Show a Favorable Safety Profile and Improvement in Efficacy Outcomes in Systemic Sclerosis and Dermatomyositis Phase 2 Studies

author_avatar
NASDAQ Market News